Identification of Ligand Templates using Local Structure Alignment for Structure-Based Drug Design

被引:21
|
作者
Lee, Hui Sun [1 ]
Im, Wonpil
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66047 USA
关键词
PROTEIN-STRUCTURE ALIGNMENT; BINDING-SITES; BOUND ALGORITHM; RECOGNITION; SIMILARITY; COMPLEX; SET;
D O I
10.1021/ci300178e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
With a rapid increase in the number of high-resolution protein ligand structures, the known protein ligand structures can be used to gain insight into ligand-binding modes in a target protein. On the basis of the fact that the structurally similar binding sites share information about their ligands, we have developed a local structure alignment tool, G-LoSA (graph-based local structure alignment). The known protein ligand binding-site structure library is searched by G-LoSA to detect binding-site structures with similar geometry and physicochemical properties to a query binding-site structure regardless of sequence continuity and protein fold. Then, the ligands in the identified complexes are used as templates (i.e., template ligands) to predict/design a ligand for the target protein. The performance of G-LoSA is validated against 76 benchmark targets from the Astex diverse set. Using the currently available protein ligand structure library, G-LoSA is able to identify a single template ligand (from a nonhomologous protein complex) that is highly similar to the target ligand in more than half of the benchmark targets. In addition, our benchmark analyses show that an assembly of structural fragments from multiple template ligands with partial similarity to the target ligand can be used to design novel ligand structures specific to the target protein. This study clearly indicates that a template-based ligand modeling has potential for de novo ligand design and can be a complementary approach to the receptor structure based methods.
引用
收藏
页码:2784 / 2795
页数:12
相关论文
共 50 条
  • [31] Realities of structure-based drug design
    Kuntz, ID
    [J]. STRUCTURE AND FUNCTION OF 7TM RECEPTORS, 1996, 39 : 392 - 399
  • [32] Exploiting ligand and receptor adaptability in rational drug design using dynamics and structure-based strategies
    LaPlante, Steven R.
    [J]. BIOACTIVE CONFORMATION I, 2007, 272 : 259 - 296
  • [33] 'Flu' and structure-based drug design
    Wade, RC
    [J]. STRUCTURE, 1997, 5 (09) : 1139 - 1145
  • [34] Advances in structure-based drug design
    Schaffhausen, Joanna
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 223 - 223
  • [35] PROTEIN STRUCTURE-BASED DRUG DESIGN
    WHITTLE, PJ
    BLUNDELL, TL
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1994, 23 : 349 - 375
  • [36] Computational approaches to structure-based ligand design
    Joseph-McCarthy, D
    [J]. PHARMACOLOGY & THERAPEUTICS, 1999, 84 (02) : 179 - 191
  • [37] Computational tools for structure-based ligand design
    Bohm, HJ
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 66 (03): : 197 - 210
  • [38] Computer-aided drug design: Integration of structure-based and ligand-based approaches in drug design
    Prathipati, Philip
    Dixit, Anshuman
    Saxena, Anil K.
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (02) : 133 - 148
  • [39] From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design
    Skalic, Miha
    Sabbadin, Davide
    Sattarov, Boris
    Sciabola, Simone
    De Fabritiis, Gianni
    [J]. MOLECULAR PHARMACEUTICS, 2019, 16 (10) : 4282 - 4291
  • [40] Structure-based ligand design to overcome CYP inhibition in drug discovery projects
    Branden, Gisela
    Sjogren, Tove
    Schnecke, Volker
    Xue, Yafeng
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (07) : 905 - 911